# FDA Inspection 1271887 - Tedor Pharma, Inc. - June 05, 2025

Source: https://www.keypedia.com/records/fda_inspections/tedor-pharma-inc/d130b166-4fa4-417a-9823-05222a5913f9
Source feed: FDA_Inspections

> FDA Inspection 1271887 for Tedor Pharma, Inc. on June 05, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1271887
- Company Name: Tedor Pharma, Inc.
- Inspection Date: 2025-06-05
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: New England District Office

## Related Documents

- [FDA Inspection 1077786 - 2019-01-31](https://www.keypedia.com/records/fda_inspections/tedor-pharma-inc/84edcb9e-8776-443a-baee-c2e86223d12a)
- [FDA Inspection 1010372 - 2017-04-20](https://www.keypedia.com/records/fda_inspections/tedor-pharma-inc/6d50ae4a-31d4-4a0a-a156-4831edc01911)
- [FDA Inspection 853221 - 2013-10-29](https://www.keypedia.com/records/fda_inspections/tedor-pharma-inc/2a849cad-1259-4b40-9631-e7fdaf65b9c6)
- [FDA Inspection 743987 - 2011-09-09](https://www.keypedia.com/records/fda_inspections/tedor-pharma-inc/ad54751b-8da0-41ba-802e-221d2e935966)

Company: https://www.keypedia.com/companies/tedor-pharma-inc/a9fa17c4-23c1-4bcf-ad03-bb9635bb063d

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144